Kristin Stephens insider trades
Open-market stock purchases and sales by Kristin Stephens, Chief Development Officer at Syros Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 15, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- SYRS Syros Pharmaceuticals, Inc: 1 sale, last Nov 18, 2024